Fritextsökning
Innehållstyper
-
Novo Nordisk invests billions in expanding its production capacity
Danish pharmaceutical company Novo Nordisk is making a major investment to develop and expand its production facility in Hillerød, north of Copenhagen. DKK 15.9...
-
Storförvärv ska öka Novo Nordisks produktionskapacitet
Novo Holding, största ägare i danska läkemedelsjätten Novo Nordisk, förvärvar den amerikanska kontraktstillverkaren Catalent i en affär på 16,5 miljarder dollar...
-
Drug development booms in Medicon Valley
When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on commission for pharmaceutical compani...
-
Ny specialtidning och nytt event i Köpenhamn – Det händer hos Life Science Sweden 2024
Det nya året bjuder på nyheter för Life Science Swedens läsare.
-
Gradientech tar in Elisabet Nielsen som vetenskaplig rådgivare
Diagnostikbolaget Gradientech rekryterar Elisabet Nielsen som vetenskaplig rådgivare i bolagets internationella vetenskapliga råd. Hon är universitetslektor och...
-
Biosimilars bring price pressure, but are they sufficiently used?
When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...
-
”The importance of stratification in a statistician’s August kitchen”
Ingrid Lönnstedt writes about an experiment of her own at home and about what lessons can be learned from it, in a science column.
-
ZEISS Quality Innovation Days
The leading digital event from April 15-19, 2024.
-
ZEISS presents the "Quality Innovation Days"
The digital event for metrology and software.
-
Samuel Lagercrantz: We are currently seeing medical breakthroughs in these areas
Samuel Lagercrantz, Editor in Chief of Life Science Sweden, lists three medical fields in which we are currently seeing major breakthroughs and two fields in wh...
-
The physician at the tech giant: “Observations in the emergency room made my mind up”
When Nasim Farrokhnia was in third grade at school in Tehran, the capital of Iran, her father gave her a book about Marie Curie, which soon became her favourite...
-
40,000 DNA extractions daily
It's great when things run quickly: 20 minutes per extraction process and a new plate every 2.5 minutes – the Dutch company Synchron Lab Automation, in cooperat...
-
Study names with an attitude – more important than you might think
Ironman, T-rex, Star-Trek. Popcorn, Proper, Scout. Nope, these are neither fantasy films nor dog names. They’re the names of ongoing cancer studies in Sweden.
-
A mass flow controller that is silent, fast and cost-effective
Portable ventilator breathing devices, bioreactors or the dosing of inert gases all rely on the highest control dynamics. That is exactly what the proportional ...
-
Internationella vaccininstitutets kontor i Sverige växer
Internationella vaccininstitutets kontor i Stockholm har nu funnits i över ett år. Under året som gått har utbildningar och projekt dragits i gång, berättar Anh...
-
Novo Nordisk sues compounding pharmacies in the US
Novo Nordisk is suing compounding pharmacies in Florida, USA, because the company claims to have found impurities in the active ingredient in the obesity drug Wegovy.
-
62-åring fick njure från gris i unik transplantation – "Återhämtar sig bra"
Amerikanska kirurger har genomfört den första transplantationen av en njure från en genmodifierad gris till en människa med njursjukdom.
-
Fetmaläkemedlet Wegovy oroar livsmedelsföretag – ”De är rädda”
Novo Nordisks vd Lars Fruergaard Jørgensen uppger att han har fått telefonsamtal från chefer i livsmedelssektorn som ser det aptitdämpande läkemedlet Wegovy som ett hot.
-
List: The coolest names in biotech
Hairy beasts, volcanic material and space strolling stand out on a US list of the best biotech company names, and on a list of the coolest names for pharmaceuti...
-
Optimism på Xspray efter uppgörelse i patenttvist
En uppgörelse uppges ha nåtts i patenttvisten mellan svenska forskningsbolaget Xspray Pharma och läkemedelsjätten Bristol Myers Squibb (BMS) om cancerkandidaten Dasynoc.
-
Recipharm divests five Swedish plants
Swedish contract manufacturer Recipharm is selling its facilities in Solna, Strängnäs, Höganäs, Karlskoga and Uppsala OTC Development to US private equity compa...
-
Betablockerare ges ofta i onödan enligt stor studie – ”Kommer påverka framtida praxis”
Patienter som drabbats av en mindre hjärtinfarkt har ingen nytta av betablockerare, enligt en ny stor studie som kan komma att ändra riktlinjer för hjärtsjukvård.
-
AstraZeneca moves to brewery quarters in central Copenhagen
AstraZeneca in Denmark is moving its business into central Copenhagen and the old brewery quarters in Carlsberg Byen.
-
Collaboration for a simpler production of gene therapies launched
A collaboration between universities and companies aims at providing better production methods for the development of gene therapies. The initiative is led by J...